459 related articles for article (PubMed ID: 17656191)
1. The presence of depression and anxiety in Parkinson's disease.
Mercury MG; Tschan W; Kehoe R; Kuechler A
Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
[No Abstract] [Full Text] [Related]
2. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
Chen JJ
Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
[No Abstract] [Full Text] [Related]
3. Anxiety and depressive disorders in college youth.
Bhave S; Nagpal J
Pediatr Clin North Am; 2005 Feb; 52(1):97-134, ix. PubMed ID: 15748927
[TBL] [Abstract][Full Text] [Related]
4. Unraveling anxiety and depression.
Mynatt S; Cunningham P
Nurse Pract; 2007 Aug; 32(8):28-36; CEU quiz 36-7. PubMed ID: 17667764
[No Abstract] [Full Text] [Related]
5. Depression in Parkinson's disease - a review.
Wermuth L; Bech P
Acta Neurol Scand; 2006 Nov; 114(5):360. PubMed ID: 17022788
[No Abstract] [Full Text] [Related]
6. Where is the room for improvement in the drug treatment of depression and anxiety?
Baldwin DS
Hum Psychopharmacol; 2011 Jan; 26(1):1-3. PubMed ID: 23055413
[No Abstract] [Full Text] [Related]
7. Prescribing hints for the treatment of anxiety and depression.
Horgan D
Aust Fam Physician; 1985 Sep; 14(9):872-5. PubMed ID: 2865944
[No Abstract] [Full Text] [Related]
8. Advances in treatment of anxiety and depressive disorders.
Lyles WB; Simpson B
J Fla Med Assoc; 1990 Aug; 77(8):731-4. PubMed ID: 1979345
[No Abstract] [Full Text] [Related]
9. [The chlorazepate test in anxiety-depressive states].
Peyre F; Bourgeois M
Ann Med Psychol (Paris); 1988; 146(7):655-62. PubMed ID: 2906229
[No Abstract] [Full Text] [Related]
10. Separation of anxiety and depressive disorders: normal rules of critical evaluation were presumably suspended.
Weeks RL
BMJ; 2003 Oct; 327(7419):869; author reply 870. PubMed ID: 14551115
[No Abstract] [Full Text] [Related]
11. Goals and challenges of optimally treating depression in a managed care environment.
Manag Care; 2002 Aug; 11(8 Suppl):3-6. PubMed ID: 12233201
[No Abstract] [Full Text] [Related]
12. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
[No Abstract] [Full Text] [Related]
13. Introduction: treating depression and anxiety to remission.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 15():3-4. PubMed ID: 14658983
[No Abstract] [Full Text] [Related]
14. Antidepressants and psychosis in Parkinson disease: a case series.
Voon V; Fox S; Butler TR; Lang AE
Int J Geriatr Psychiatry; 2007 Jun; 22(6):601-4. PubMed ID: 17450623
[No Abstract] [Full Text] [Related]
15. Depression in Parkinson's disease.
Brooks DJ; Doder M
Curr Opin Neurol; 2001 Aug; 14(4):465-70. PubMed ID: 11470962
[No Abstract] [Full Text] [Related]
16. Depression & anxiety in the primary care setting.
Cunningham LA
Compr Ther; 1997 Jun; 23(6):400-6. PubMed ID: 9239490
[TBL] [Abstract][Full Text] [Related]
17. [Psychiatric disorders in elderly patients with Parkinson's disease and their treatments].
Reynaud G; von Gunten A; Küng A
Rev Med Suisse Romande; 2001 Feb; 121(2):145-51. PubMed ID: 11285697
[TBL] [Abstract][Full Text] [Related]
18. Anxiety and mood disorders in medically ill patients.
Wise MG; Taylor SE
J Clin Psychiatry; 1990 Jan; 51 Suppl():27-32. PubMed ID: 2404001
[TBL] [Abstract][Full Text] [Related]
19. Psychosis, apathy, depression and anxiety in Parkinson's disease.
Gallagher DA; Schrag A
Neurobiol Dis; 2012 Jun; 46(3):581-9. PubMed ID: 22245219
[TBL] [Abstract][Full Text] [Related]
20. Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management.
Torta R; Pennazio F; Ieraci V
Reumatismo; 2014 Jun; 66(1):92-7. PubMed ID: 24938201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
